IL141878A0 - Expression vectors containing hot spot for increased recombinant protein expression in transfected cells - Google Patents

Expression vectors containing hot spot for increased recombinant protein expression in transfected cells

Info

Publication number
IL141878A0
IL141878A0 IL14187899A IL14187899A IL141878A0 IL 141878 A0 IL141878 A0 IL 141878A0 IL 14187899 A IL14187899 A IL 14187899A IL 14187899 A IL14187899 A IL 14187899A IL 141878 A0 IL141878 A0 IL 141878A0
Authority
IL
Israel
Prior art keywords
hot spot
expression
recombinant protein
transfected cells
vectors containing
Prior art date
Application number
IL14187899A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL141878A0 publication Critical patent/IL141878A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14187899A 1998-09-22 1999-09-07 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells IL141878A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10129298P 1998-09-22 1998-09-22
PCT/US1999/020467 WO2000017337A1 (en) 1998-09-22 1999-09-07 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells

Publications (1)

Publication Number Publication Date
IL141878A0 true IL141878A0 (en) 2002-03-10

Family

ID=22283889

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14187899A IL141878A0 (en) 1998-09-22 1999-09-07 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells

Country Status (10)

Country Link
US (1) US6521419B1 (xx)
EP (1) EP1115852B1 (xx)
JP (1) JP4480893B2 (xx)
AT (1) ATE290073T1 (xx)
AU (1) AU762274B2 (xx)
CA (1) CA2344699A1 (xx)
DE (1) DE69923983T2 (xx)
ES (1) ES2237943T3 (xx)
IL (1) IL141878A0 (xx)
WO (1) WO2000017337A1 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800457B2 (en) * 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
ATE466944T1 (de) 2001-07-04 2010-05-15 Chromagenics Bv Dns-sequenzen mit anti-repressor aktivität
CA2385110A1 (en) * 2002-05-06 2003-11-06 University Of British Columbia Co-expression system for large functional proteins
WO2003106674A2 (en) * 2002-06-14 2003-12-24 Chromagenics B.V. Means and methods for regulating gene expression
WO2003106684A2 (en) * 2002-06-14 2003-12-24 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
NZ540471A (en) * 2002-12-18 2008-07-31 Chromagenics Bv A method for improving protein production
WO2004056986A2 (en) * 2002-12-20 2004-07-08 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
WO2006048459A2 (en) * 2004-11-08 2006-05-11 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) * 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060172382A1 (en) * 2004-11-08 2006-08-03 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
AR058568A1 (es) 2005-12-20 2008-02-13 Bristol Myers Squibb Co Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
PL1969007T4 (pl) 2005-12-20 2014-04-30 Bristol Myers Squibb Co Kompozycje i sposoby wytwarzania kompozycji
EP3311877A1 (en) 2007-07-19 2018-04-25 Medical Components, Inc. Venous access port assembly with x-ray discernable indicia
EP2612868B1 (en) * 2007-11-01 2018-08-15 Astellas Pharma Inc. Immunosuppressive polypeptides and nucleic acids
WO2010023787A1 (ja) * 2008-08-29 2010-03-04 東洋紡績株式会社 遺伝子発現安定化エレメント
CN103305504B (zh) * 2012-03-14 2016-08-10 江苏吉锐生物技术有限公司 在仓鼠细胞中定点重组的组合物和方法
BR112017008022A2 (pt) 2014-10-23 2018-02-20 Regeneron Pharmaceuticals, Inc. célula, polinucleotídeo, veículo, e, métodos para modificação de um genoma de células cho e para preparação de uma proteína de interesse.
AU2018315428A1 (en) 2017-08-11 2020-01-16 Boehringer Ingelheim International Gmbh Integration sites in CHO cells
US20220170047A1 (en) 2019-04-02 2022-06-02 Chugai Seiyaku Kabushiki Kaisha Method of introducing target-specific foreign gene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844095A (en) 1991-06-27 1998-12-01 Bristol-Myers Squibb Company CTLA4 Ig fusion proteins
DE69226871T3 (de) 1991-06-27 2009-09-24 Bristol-Myers Squibb Co. CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung
US5747034A (en) 1992-07-09 1998-05-05 Chiron Corporation Methods and materials for the induction of T cell anergy
US5773253A (en) 1993-01-22 1998-06-30 Bristol-Myers Squibb Company MYPPPY variants of CTL A4 and uses thereof
GB2299336A (en) 1993-12-23 1996-10-02 Merck & Co Inc Homologous recombination antibody expression sysstem for murine cells
NZ330926A (en) 1996-01-11 1999-11-29 Immunex Corp Expression augmenting sequence elements (ease) for eukaryotic expression systems

Also Published As

Publication number Publication date
DE69923983T2 (de) 2006-04-06
DE69923983D1 (de) 2005-04-07
EP1115852A4 (en) 2002-09-25
US6521419B1 (en) 2003-02-18
ATE290073T1 (de) 2005-03-15
AU6137599A (en) 2000-04-10
JP2002526071A (ja) 2002-08-20
WO2000017337A1 (en) 2000-03-30
CA2344699A1 (en) 2000-03-30
AU762274B2 (en) 2003-06-19
EP1115852A1 (en) 2001-07-18
EP1115852B1 (en) 2005-03-02
JP4480893B2 (ja) 2010-06-16
ES2237943T3 (es) 2005-08-01

Similar Documents

Publication Publication Date Title
IL141878A0 (en) Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
EP0786989A4 (en) LIPID VESICLES CONTAINING THE REP PROTEIN OF ADENO-ASSOCIATED VIRUSES FOR TRANSGENIC INTEGRATION AND GENE THERAPY
CA2198497A1 (en) Acetohydroxyacid synthase promoter for expression of introduced genes in plants
PL335695A1 (en) Method of integrating genes into a specific place of mammal cell genome by honologous recombination and vectors serving that purpose
HU9601467D0 (en) Homologous recombination antibody expression system for murine cells
WO2000028061A3 (en) Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
EP1453543A4 (en) APE-ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES; THOSE CONTAINING VECTORS AND METHOD OF USE
MY137837A (en) Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
WO1995007995A3 (en) Adeno-associated viral (aav) liposomes and methods related thereto
WO1995006743A3 (en) Methods and compositions for the large scale production of recombinant adeno-associated virus
AU6047598A (en) Arginine deiminase derived from (mycoplasma arthritidis) and polymer conjugates containing the same
CA2309755A1 (en) Hormone-dependent forms of the adeno-associated virus, rep proteins, dna sequences coding for them, vectors containing them, and regulatory methods of their intracellular activity
TR199802503A2 (xx) Endojen gen aktivasyonu i�in h�crelerin optimizasyonu.
EP1005559A4 (en) IMPROVED SYSTEM FOR CLONING BY INACTIVATION OF A VECTOR CONTAINER
WO1998055639A3 (fr) Vecteurs adenoviraux recombinants comprenant une sequence d'epissage
GR3035599T3 (en) Methods for selection of recombinant host cells expressing high levels of a desired protein
Oakeley et al. Non-symmetrical cytosine methylation in tobacco pollen DNA
ZA200404424B (en) Genes encoding for genetic stability, gene expression and folding proteins.
MX9707910A (es) Vector viral recombinante inducible por la glucosa.
DE69940267D1 (de) Wirtszellen, die rekombinantes humanes erythropoietin exprimieren
ATE342998T1 (de) Replikation -defektive baculoviren expressionssystem
EP1845163A3 (en) Adeno-associated virus serotype l nucleic acid sequences, vetors and host cells containing same
AU4712497A (en) Retroviral vectors
CA2228394A1 (en) Novel catalase, the gene thereof and composition comprising the same, and process for preparing catalase using genetic engineering technology
EP0924295A3 (en) DNA encoding neospora dihydrofolate reductase-thymidylate synthase